Meaning-Centered Psychotherapy in Advanced Cancer


Phase 2
21 Years
N/A
Not Enrolling
Both
Lymphoma, Non-Hodgkin, Neoplasms

Thank you

Trial Information

Meaning-Centered Psychotherapy in Advanced Cancer


As per Brief Summary


Inclusion Criteria:



- 21 years of age or older;

- English speaking;

- Stage III or IV solid-tumor or Non-Hodgkin's Lymphoma;

- Receiving ambulatory care at Memorial Sloan-Kettering Cancer Center in New York City;

Exclusion Criteria:

- Significant psychiatric disturbance sufficient, in the investigator's judgment, to
preclude participation in a group-format intervention;

- Presence of cognitive impairment disorder, such as delirium or dementia that is
sufficient, in the investigator's opinion, to preclude meaningful participation
and/or informed consent;

- Karnofsky Performance Rating Scale below 50 or physical limitations or illness
severity sufficient to preclude participation in outpatient group psychotherapy.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Educational/Counseling/Training

Principal Investigator

William Breitbart, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Federal Government

Study ID:

R21 AT001031-01

NCT ID:

NCT00067288

Start Date:

May 2002

Completion Date:

March 2006

Related Keywords:

  • Lymphoma, Non-Hodgkin
  • Neoplasms
  • Stage 3 cancer;
  • Stage 4 cancer;
  • solid tumor cancer;
  • Non-Hodgkin's Lymphoma;
  • solid tumors;
  • end-stage cancer;
  • group psychotherapy;
  • psychotherapy;
  • emotional support;
  • support groups
  • Neoplasms
  • Lymphoma
  • Lymphoma, Non-Hodgkin

Name

Location
Memorial Sloan-Kettering Institute for Cancer Research New York, New York  10021